Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility : a randomised controlled trial
Citation
Price , D B , Buhl , R , Chan , A , Freeman , D , Gardener , E , Godley , C , Gruffydd-Jones , K , McGarvey , L , Ohta , K , Ryan , D , Syk , J , Tan , N C , Tan , T , Thomas , M , Yang , S , Konduru , P R , Ngantcha , M , d'Alcontres , M S & Lapperre , T S 2018 , ' Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility : a randomised controlled trial ' , The Lancet. Respiratory medicine , vol. 6 , no. 1 , pp. 29-39 . https://doi.org/10.1016/S2213-2600(17)30424-1